There are about 54 million Medicare-eligible persons in the United States and its territories. As of March 2015, 17.3 million were enrolled in Medicare Advantage, according to a recent Mark Farrah Associates report. (MFA Report) That is over 30% of the eligible population. Membership in MA plans increased by 1.3 million, or 8%, on a year-over-year basis, excellent growth considering concerns about reimbursement. The top ten plans account for 67% of membership, with UnitedHealth Group leading the way with 3,448,000 members, 8.5% growth from March 2014 and a 20% market share. Following were Humana with 3,181,00, 13.2% growth and an 18.4% share; then Kaiser at 1,295,000 enrollees, 6.95 growth and 7.5% share; Aetna with 1,251,000, a 13.9% increase and a 7.2% market share; Anthem, the only leader to show a decline, with 582,000 enrollees, a 12.5% decrease and only a 3.4% share, and lastly, Cigna at 496,000 members, 9% growth and a 2.9% share. Most of these Medicare Advantage members enrolled individually, but about 18% came through groups, as employers see MA as a way to control health spending on older employees or retirees. Most of these members, 62%, were in an HMO plan design and another 31% were in PPO designs. There was a large increase in dual-eligible enrollment, up to 300,000 people from only 9,000 in 2014, largely because a number of states started new initiatives to place most of their Medicaid/Medicare population into managed care plans. Overall, very significant member and revenue growth opportunities seem to exist for MA plans, and as large number of people become eligible for Medicare in the next decade, many have been in health plans for most of their lives and will be comfortable with the MA concept. Within a few years Medicare Advantage could account for 50% or more of Medicare beneficiaries and program officials will have to consider whether the fee-for-service side is really worth hanging onto.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 19, 2024
Another Body Blow to Gender Dis-Affirmation
A review from Britain reveals the complete lack of any scientific evidence to support the…
Commentary
April 18, 2024
Progress Against Cancer
The US has made particularly good progress in treating cancer and limiting mortality, but much…
Commentary
April 17, 2024
I Am Done With Coronamonomania, Part 4, Vax Safety Edition
A somewhat lengthy examination of recent studies related mostly to vax safety, the results of…